Jan. 28, 2022. Updated to include per diem rate increase and changes to the for submission of baseline wage data requirement regarding eligible direct care worker wage increase from eligible ICF-IID providers.
Topics Related to COVID-19
FDA has expanded the use of single booster dose to include ages 12-15.
Reinstatement of temporary suspension of prior authorization for inpatient rehabilitation hospital and long-term care hospital admissions under NC Medicaid Managed Care.
Emergency use of Evusheld approved by FDA
Providers should bill with Revenue Code 0771 instead of Revenue Code 0261 on future claims for the vaccine and monoclonal antibody administration services.
Reimbursement for COVID-19 Specimen Collection
This group includes MAFDN Family Planning Medicaid and uninsured MCV beneficiaries.
Beginning Dec. 9, 2021, Medicaid and NC Health Choice will cover the Pfizer-BioNTech COVID-19 vaccine booster dose for administration to individuals age 16 and older.
COVID-19 vaccination has been approved for all pediatric patients who meet specific criteria regarding COVID-19.
Effective Dec. 31, 2021, NC Medicaid will end several of the temporary COVID-19 rate increases. Some of the rate increases in effect in December 2021 will be extended – at either current or revised levels - through Jan. 31, 2022.